Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sujuan Peng"'
Autor:
Sujuan Peng, Hongxiang Huang, Jinhong Chen, Xinjing Ding, Xie Zhu, Yangyang Liu, Li Chen, Zhihui Lu
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Introduction: The 2019 coronavirus disease (COVID-19) pandemic has reshaped oncology practice, but the impact of anti-angiogenic drugs on the severity of COVID-19 in patients with non-small cell lung cancer (NSCLC) remains unclear. Patients and Metho
Externí odkaz:
https://doaj.org/article/74923c4d8b22461c996ac4150f403b6c
Publikováno v:
In Digital Chinese Medicine March 2022 5(1):18-32
Autor:
Hongxiang Huang, Peiyuan Zhong, Xie Zhu, Silv Fu, Siling Li, Sujuan Peng, Yangyang Liu, Zhihui Lu, Li Chen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundDespite the fact that numerous clinical and preclinical studies have demonstrated the synergistic effects of combining antiangiogenic or chemotherapy with immunotherapy, no data have been found to indicate that combination therapy is more e
Externí odkaz:
https://doaj.org/article/5792eb139d0e4c2f841eb568f070e0dd
Autor:
Silv Fu, Hongxiang Huang, Kai Shang, Ganjie Tu, Peiyuan Zhong, Siling Li, Xie Zhu, Sujuan Peng, Yangyang Liu, Zhihui Lu, Li Chen
Publikováno v:
Future Oncology. 19:147-158
Aim: To assess the efficacy and safety of combination of PD-1 inhibitors, recombinant human endostatin (Rh-endostatin) and chemotherapy as first-line treatment for advanced non-small-cell lung cancer (NSCLC). Methods: A total of 100 patients with adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c304e2f5a59e8eb7eb2c6a9c0934725
https://doi.org/10.2217/fon-2022-0861
https://doi.org/10.2217/fon-2022-0861
Autor:
CaiLan, Zhou, Yi, Tan, YuYu, Wang, FangPing, Liao, QiuLing, Wang, JingLin, Li, SuJuan, Peng, XiaoWu, Peng, YunFeng, Zou
Publikováno v:
Ecotoxicology and environmental safety. 196
Several studies have demonstrated that PM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03208e9e15df437e5a86886035de4807
https://pubmed.ncbi.nlm.nih.gov/32278143
https://pubmed.ncbi.nlm.nih.gov/32278143
Autor:
SuJuan Peng, XiaoWu Peng, Yi Tan, QiuLing Wang, JingLin Li, YuYu Wang, FangPing Liao, CaiLan Zhou, Yunfeng Zou
Publikováno v:
Ecotoxicology and Environmental Safety. 196:110476
Several studies have demonstrated that PM2.5 inhalation is associated with an increased risk of cerebrovascular disease (CVD), in which inflammation plays an important role. The mechanisms of this disease are not fully understood to date. Long non-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07751c72377ded1aa733c6d3d9165165
https://doi.org/10.1016/j.ecoenv.2020.110476
https://doi.org/10.1016/j.ecoenv.2020.110476
Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.
Autor:
Peng, Sujuan, Huang, Hongxiang, Chen, Jinhong, Ding, Xinjing, Zhu, Xie, Liu, Yangyang, Chen, Li, Lu, Zhihui
Publikováno v:
Technology in Cancer Research & Treatment; 4/24/2024, p1-14, 14p
Autor:
Peng, Sujuan1 (AUTHOR), Huang, Hongxiang1 (AUTHOR), Zhu, Xie1 (AUTHOR), Chen, Jinhong1 (AUTHOR), Ding, Xinjing1 (AUTHOR), Wang, Fen1 (AUTHOR), Chen, Li1 (AUTHOR) ndyfy01985@ncu.edu.cn, Lu, Zhihui1 (AUTHOR) ndyfy01985@ncu.edu.cn
Publikováno v:
Experimental & Therapeutic Medicine. May2024, Vol. 27 Issue 5, pN.PAG-N.PAG. 1p.
Publikováno v:
Immunotherapy Weekly; 5/7/2024, p1073-1073, 1p
Publikováno v:
Drug Week; 2/28/2023, p1335-1335, 1p